BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Brilakis L, Theofilogiannakou E, Lykoudis PM. Current remarks and future directions on the interactions between metabolic dysfunction-associated fatty liver disease and COVID-19. World J Gastroenterol 2024; 30(11): 1480-1487 [PMID: 38617460 DOI: 10.3748/wjg.v30.i11.1480]
URL: https://www.wjgnet.com/2307-8960/full/v30/i11/1480.htm
Number Citing Articles
1
Daniel Romero-Suárez, José Belisario Solana Tinoco, María Cecilia García-Espiñeira, Lina Lambis-Anaya, Amileth Suarez-Causado. Expression of TWEAK/Fn14 axis in the context of metabolic dysfunction associated-fatty liver disease: an approach in liver regenerationRevista de Gastroenterología del Perú 2024; 44(3): 259 doi: 10.47892/rgp.2024.443.1718
2
Ieva Vanaga, Oksana Kolesova, Aleksandrs Kolesovs, Maija Radzina, Davis Simanis Putrins, Jelena Egle, Sniedze Laivacuma, Jelena Storozenko, Ludmila Viksna. Liver-Related COVID-19 Consequences: Dynamics of Liver Health in 2.5 YearsJournal of Clinical Medicine 2025; 14(21): 7604 doi: 10.3390/jcm14217604